Silvant Capital Management LLC Madrigal Pharmaceuticals, Inc. Transaction History

Silvant Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 07, 2022	SELL	$72.34 - $95.09 $5,642 - $7,417	-78 Reduced 6.04%	1,213 $103,000
Q3 2019 Nov 12, 2019	BUY	$84.4 - $106.53 $52,750 - $66,581	625 Added 93.84%	1,291 $111,000
Q3 2018 Nov 07, 2018	BUY	$207.3 - $300.31 $38,350 - $55,557	185 Added 38.46%	666 $143,000
Q2 2018 Aug 13, 2018	BUY	$101.55 - $313.9 $48,845 - $150,985	481 New	481 $135,000

297

22M

819K

640K

Ticker MDGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,103,400
Market Cap $5.34B
Description
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...

Get notified when there are updates to the investment portfolio of Silvant Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Silvant Capital Management LLC with notifications on news.